Alkem Laboratories Ltd. Financials: Quarterly Results
Revenue
3879.92
Cr.
PAT
653.53
Cr.
EBITDA
876.09
Cr.
Alkem Laboratories Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 3736.82 | 4000.99 | 3371.14 | 3143.75 | 3374.28 |
| Total Income From Operations (Cr.) | 3736.82 | 4000.99 | 3371.14 | 3143.75 | 3374.28 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 876.09 | 930.85 | 787.86 | 424.76 | 767.10 |
| P/L Before Exceptional Items & Tax (Cr.) | 833.99 | 895.83 | 758.08 | 396.34 | 731.07 |
| P/L After Tax from Ordinary Activities (Cr.) | 653.53 | 779.60 | 668.32 | 323.01 | 640.79 |
| Net Profit/Loss For the Period (Cr.) | 653.53 | 779.60 | 668.32 | 323.01 | 640.79 |
| Basic EPS | 53.19 | 63.99 | 55.56 | 25.57 | 52.34 |
FAQs
Alkem Laboratories Ltd. announced its quarterly results for Q3 FY2026 on February 13, 2026.
In Q3 FY2026, Alkem Laboratories Ltd. are as follows:
Revenue: ₹3879.92 crore
Net Profit: ₹653.53 crore.
For Q3 FY2026, Alkem Laboratories Ltd. posted ₹3879.92 crore in revenue and ₹653.53 crore in net profit.
Past quarterly results for Alkem Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.